







Appendix A: Physical constants 
Compounds Color Molecular formula Mwt. ΛM/Scm2mol-1 Mass spectra (m/z) C H N 







Cu(LSP) Green C13H19Cl2N3OCu 367.16 31.98 -    
Zn(LSP) Pale yellow C13H19Cl2N3OZn 369.63 30.87 -    
Cd(LSP) White C13H19Cl2N3OCd 416.63 30.94 -    







Cu(LCS) Green C13H18Cl3N3OCu 402.21 36.25 -    
Zn(LCS) White C13H18Cl3N3OZn 404.07 36.39 -    
Cd(LCS) White C13H18Cl3N3OCd 451.07 36.42 -    







Cu(LBS) Green C13H18Cl2BrN3OCu 446.66 36.98 -    
Zn(LBS) Pale-yellow C13H18Cl2BrN3OZn 448.52 36.25 -    
Cd(LBS) White C13H18Cl2BrN3OCd 495.52 36.33 -    







Cu(LNS) Green C13H18CuCl2N4O3 412.76 37.12 -    
Zn(LNS) Yellow C13H18ZnCl2N4O3 414.62 36.69 -    
Cd(LNS) Yellow C13H18CdCl2N4O3 461.62 36.71 -    







Cu(LDH) Green C13H19Cl2N3O2Cu 383.76 35.44 -    
Zn(LDH) White C13H19Cl2N3O2Zn 385.62 35.68 -    






Appendix A: Physical constants 
Compounds Color Formula weight Mwt. ΛM/Scm2mol-1 Mass spectra (m/z) C H N 







Cu(DHS) Green C13H19Cl2N3O2Cu 383.76 35.31 -    
Zn(DHS) Yellowish C13H19Cl2N3O2Zn 385.62 34.98 -    
Cd(DHS) White C13H19Cl2N3O2Cd 432.63 34.95 -    







Cu(LHM) Green C14H21Cl2CuN3O2 397.79 35.63 -    
Zn(LHM) Yellow C14H21Cl2ZnN3O2 399.65 35.42 -    
Cd(LHM) Yellowish C14H21Cl2CdN3O2 446.65 35.39 -    







Cu(HMS) Green C14H21Cl2CuN3O2 397.79 35.21 -    
Zn(HMS) Brownish C14H21Cl2ZnN3O2 399.65 35.09 -    
Cd(HMS) Brownish C14H21Cl2CdN3O2 446.65 35.17 -    







Cu(2HP) Green C14H22Cl2CuN3O 381.79 25.45 -    
Zn(2HP) White C14H22Cl2ZnN3O 383.65 25.24 -    
Cd(2HP) White C14H22Cl2CdN3O 430.65 25.12 -    







Cu(DHP) Green C14H21Cl2CuN3O2 397.79 37.21 -    
Zn(DHP) White C14H21Cl2ZnN3O2 399.65 36.98 -    
























































































Figure 3.31 IR spectra of [Zn(HMS)Cl2] complex. 
 
 






Figure 3.35 IR spectra of [Zn(2HP)Cl2] complex. 
 
 
















Appendix C: 1H NMR spectra of zinc and cadmium complexes (ppm) 
 
 
Figure 3.42 1H NMR spectra of [Zn(LSP)Cl2] complex. 
 
 






Figure 3.45 1H NMR spectra of [Zn(LCS)Cl2] complex. 
 
 







Figure 3.48 1H NMR spectra of [Zn(LBS)Cl2] complex. 
 
 








































Figure 3.60 1H NMR spectra of [Zn(LHM)Cl2] complex. 
 
 


















Figure 3.66 1H NMR spectra of [Zn(2HP)Cl2] complex. 
 
 




































































































Figure 3.96 13C NMR spectra of [Zn(2HP)Cl2] complex. 
 
 






Figure 3.99 13C NMR spectra of [Zn(DHP)Cl2] complex. 
 
 







































































Figure 3.127 UV-visible spectra of [Zn(LHM)Cl2] complex. 
 
 

















































Figure 3.145 TGA curve of [Zn(LCS)Cl2] complex. 
 
 




















































































Appendix G: Tables for X-ray analysis 
Table 3.51 Crystal data and structure refinement for [Zn(LNS)Cl2 
Identification code [Zn(LNS)Cl2] 
Empirical formula   C13 H20 Cl2 N4 O4 Zn 
Formula weight  432.6 
Temperature (K)    100(2)  
Crystal system , Space group   Triclinic, P -1 
Unit cell dimensions 
a (Å) 9.4512(2) 
b (Å) 9.5927(2) 
c (Å) 10.2076(2) 
α (°) 105.9350(10) 
β (°) 102.7190(10) 
γ (°) 95.2310(10) 
Volume (Å3)  856.63(3) 
Z, Density (calculated) (g cm-3)  2, 1.677 
Absorption coefficient (mm-1)  1.771 
F(000)  444 
Crystal size (mm3)  0.24 x 0.20 x 0.16 
θ range for data collection (°)  2.15 to 27.50 
Index ranges -12<=h<=12, -12<=k<=12, -
13<=l<=13 
 Reflections collected / unique 8149 / 3914 [Rint = 0.0135]  
Completeness  To θ = 27.50, 99.4 %  
Max. and min. transmission  0.7648 and 0.6759  
Data / restraints / parameters  3914 / 4 / 229  
Goodness-of-fit on F2 1.073  
Final R indices [I>2σ (I)]  R1 = 0.0218, wR2 = 0.0579  
R indices (all data)  R1 = 0.0240, wR2 = 0.0589  



























Table 3.53 Crystal data and structure refinement for [Zn(LDH)Cl2] 
 
Identification code [Zn(LDH)Cl2] 
Empirical formula C13 H21 Cl2 N3 O3 Zn 
Formula weight 403.6 
Temperature (K) 100(2)  
Crystal system , Space group Monoclinic, C 2/c 
Unit cell dimensions 
A (Å) 16.6101(10) 
B (Å) 10.0652(6) 
C (Å) 20.2141(10) 
Α (°)  
Β (°) 96.983(4) 
γ (°)  
Volume (Å3)  3354.4(3) 
Z, Density (calculated) (g cm-3)  8, 1.598  
Absorption coefficient (mm-1)  1.797 
F(000)  1664 
Crystal size (mm3)  0.21 x 0.12 x 0.04 
Θ range for data collection (°)  2.37 to 27.50  
Index ranges -21<=h<=21, -13<=k<=12, -26<=l<=26 
Reflections collected / unique 12197 / 3833 [Rint = 0.0403]  
Completeness  To θ = 27.50: 99.4 %  
Max. and min. transmission  0.9316 and 0.7041  
Data / restraints / parameters  3833 / 5 / 214  
Goodness-of-fit on F2 1.036 
Final R indices [I>2σ (I)]  R1 = 0.0335, wR2 = 0.0754  
R indices (all data)  R1 = 0.0435, wR2 = 0.0795  
Largest diff. peak and hole (e.Å-3) 0.546 and -0.575  
 


















Table 3.55Crystal data and structure refinement for ZnHMS 
 
Identification code [Zn(HMS)Cl2] 
Empirical formula C14 H23 Cl2 N3 O3 Zn 
Formula weight  417.62 
Temperature (K) 100(2)  
Crystal system , Space group Monoclinic, P 21/n 
Unit cell dimensions 
a (Å) 7.06570(10) 
b (Å)  13.7154(2) 
c (Å)  18.3058(2) 
β (°)  95.7700(10)  
Volume (Å3)  1765.01(4) 
Z, Density (calculated) (g cm-3)  4, 1.572  
Absorption coefficient (mm-1)  1.711 
F(000)  864 
Crystal size (mm3)  0.27 x 0.24 x 0.12 
θ range for data collection  (°)  2.24 to 26.00 
Index ranges -8<=h<=8, -16<=k<=16, -22<=l<=22 
 Reflections collected / unique 14604 /3455 [Rint = 0.0267]  
Completeness  To θ = 26.00°: 99.8%  
Max. and min. transmission  0.8211 and 0.6552 
Data / restraints / parameters  3455 / 2 / 225   
Goodness-of-fit on F2 1.064 
Final R indices [I>2σ (I)]  R1 = 0.0343, wR2 = 0.0883 
R indices (all data)  R1 = 0.0397, wR2 = 0.0923 

























Table 3.57 Hydrogen-bond geometry for zinc(II) complexes. 
 
Complexes D-H...A H…A (Å) D...A (Å) D-H…A 
(°) 
N(3)-H(3B)...Cl(1)#3 2.639(17) 3.3567(15) 139.4(15) [Zn(LNS)Cl2] N(3)-H(3B)...Cl(2)#3 2.809(18) 3.4742(14) 133.5(14) 
N(3)-H(3A)...O(1)#4 1.750(19) 2.651(2) 170(3) [Zn(LDH)Cl2] N(3)-H(3B)...Cl(1)#5 2.36(2) 3.191(2) 159(2) 






Table 3.58 Crystal data and structure refinement for [Cd(LSP)Cl2] 
 
Identification code [Cd(LSP)Cl2] 
Empirical formula [CdCl2(C13H19N3O)] 
Formula weight  416.61 
Temperature (K) 100 
Crystal system , Space group Orthorhombic pbca 
Unit cell dimensions 
a (Å) 14.7512 
b (Å)  13.1406 
c (Å)  16.6188 
λ (Å) 0.71073  
Volume (Å3)  3221 
Z, Density (calculated) (g cm-3)  8 
Absorption coefficient (mm-1)  1.69 
F(000)  1664 
Crystal size (mm3)  0.45 × 0.39 × 0.18 
θ range for data collection  (°)  2.4-31.3 
Index ranges h = −19→19, k = −17→17, l = 
−21→21 
 Reflections collected / unique 3700/3409 [Rint=0.041] 
Completeness  Toθ = 27.5, 99.8% 
Max. and min. transmission  0.751 and 0.518 
Data / restraints / parameters  3700/2/187 
Goodness-of-fit on F2 1.06 
Final R indices [I>2σ (I)]  R1=0.017,wR2= 0.045 
R indices (all data)  R1= 0.002, wR20.44 








Bond length  
Cd1—N1  2.2693 (13) 
Cd1—O1  2.2740 (11) 
Cd1—Cl2  2.4557 (4) 
Cd1—Cl1  2.4904 (4) 
Cd1—N2  2.5209 (13) 
Bond Angle 
N1—Cd1—O1 80.22 (4) 
N1—Cd1—Cl2  132.92 (3) 
O1—Cd1—Cl2  90.39 (3) 
N1—Cd1—Cl1  118.77 (3) 
O1—Cd1—Cl1  102.57 (3) 
Cl2—Cd1—Cl1  108.309 (15) 
N1—Cd1—N2  75.55 (4) 
O1—Cd1—N2  155.52 (4) 
Cl2—Cd1—N2  103.45 (3) 








Identification code [Cd(LHM)Cl2] 
Empirical formula [CdCl2(C14H21N3O2)] 
Formula weight  446.64 
Temperature (K) 100 
Crystal system , Space group Monoclinic, P21/c 
Unit cell dimensions 
a (Å) 10.1173 
b (Å)  16.2686 (15) 
c (Å)  10.3486 (10) 
β(Å) 103.069 (1) 
Volume (Å3)  1659.2 (3) 
Z, Density (calculated) (g cm-3)  4 
Absorption coefficient (mm-1)  1.65 
F(000)  896 
Crystal size (mm3)  0.25 × 0.18 × 0.04 
θ range for data collection  (°)  2.4–30.3° 
Index ranges h = −12→12, k = −20→20, l = −12→13 
 Reflections collected / unique 3624/3138 [Rint=0.04] 
Completeness  To θ = 27o, 99.8%  
Max. and min. transmission  0.937 and 0.684 
Data / restraints / parameters  3624/5/225 
Goodness-of-fit on F2 1.07 
Final R indices [I>2σ (I)]  R1 = 0.031, wR2 = 0.061 
R indices (all data)  R1 = 0.001, wR2 = 0.65 




Table 3.61 Selected bond length (Å) and bond angles for [Cd(LHM)Cl2] 
 
 
Table 3.62 Hydrogen-bond geometry for cadmium(II) complexes. 
 
 
Bond length  
Cd1—O1  2.241 (2) 
Cd1—N1  2.245 (3) 
Cd1—N2  2.475 (2) 
Cd1—Cl1  2.4584 (8) 
Cd1—Cl2  2.4797 (8) 
Bond Angle 
O1—Cd1—N1  82.23 (9) 
O1—Cd1—Cl1  92.75 (6) 
N1—Cd1—Cl1  135.90 (10) 
O1—Cd1—N2  153.88 (8) 
N1—Cd1—N2  74.96 (9) 
Cl1—Cd1—N2  94.82 (6) 
O1—Cd1—Cl2  104.60 (6) 
N1—Cd1—Cl2  117.46 (9) 
Cl1—Cd1—Cl2  106.24 (3) 
N2—Cd1—Cl2  97.20 (7) 
Complexes D-H...A H…A (Å) D...A (Å) D-H…A 
(°) 
N(3)-H(3A)...Cl(1)i 2.53 (2) 3.3108 (14) 146 (2) 
[Cd(LSP)Cl2] N(3)-H(3A)...Cl(2)ii 2.78 (2) 3.2689 (14) 116 (2) 
N(3)-H(3A)...O(1)i 1.80 (2) 2.705 (3) 166 (4) 




Appendix H: Acute toxicity results 
Table 3.63 Effect of zinc complexes on the renal functions 
Indices Normal [Zn(LSP)Cl2] [Zn(LCS)Cl2] [Zn(LBS)Cl2] 
Sodium 139.5 ± 2.6 139.2 ± 2.4 138.2 ± 2.7 138.5 ± 2.9 
Potassium 5.05 ± 0.8 5.50 ± 0.6 4.70 ± 0.9 5.100 ± 0.7 
Chloride 103.8 ± 1.3 104.6 ± 2.3 105.1 ± 1.2 102.3 ± 1.7 
CO2 23.9 ± 2.1 22.2 ± 2.6 21.3 ± 3.2 23.10 ± 3.3 
Anion gap 17.4 ± 1.2 18.5 ± 0.7 16.5 ± 3.1 18.50 ± 3.5 
Urea 6.10 ± 1.3 7.40 ± 0.6 7.60 ± 1.7 9.300 ± 2.6 
Creatinine 42.5 ± 1.9 28.4 ± 17 40.8 ± 1.9 50.50 ± 1.9 
 
Table 3.64 Effects of zinc complexes on the liver functions 
Indices Normal [Zn(LSP)Cl2] [Zn(LCS)Cl2] [Zn(LBS)Cl2] 
Total protein 70.5 ± 3.6 87.3 ± 4.9 75.5 ± 3.2 81.8 ± 2.6 
Albumin 59.5 ± 2.4 68.6 ± 4.1 62.5 ± 3.2 69.3 ± 0.5 
Globulin 59.5 ± 3.4 69.5 ± 4.9 61.9 ± 2.2 65.3 ± 2.4 
Alk. Phosphate 59.30 ± 11.3 81.30 ± 10.8  82.3 ± 11.3 92.80+12.5 
ALT 49.8 ± 7.2 61.0 ± 3.6 57.8 ± 3.4 55.3 ± 4.9 
AST 259.8 ± 12.7 292.3 ± 10.6 278.5 ± 9.8 281.5 ± 12.6 
Total bilirubin 6.25 ± 0.5 7.50 ± 0.7 6.88 ± 0.8 7.32 ± 0.8 
C.bilurubin 3.61 ± 0.9 5.83 ± 1.3 3.85 ± 1.4 4.22 ± 2.1 
Triglyceride 0.45 ± 0.1 0.60 ± 0.4 0.30 ± 0.05 0.80 ± 0.8 
Total cholesterol 2.20 ± 0.3 3.70 ± 0.5 3.30 ± 0.1 3.6 0± 0.4 






Figure 3.176 Histological views of liver and kidney in acute toxicity studies 
A (Liver of the normal rat), B (Liver of the male rat), C (Liver of the female rat) D (Kidney of the normal rat), E (Kidney of the 




Appendix I: Molecular docking results 
 
Figure 3.177  
(A)A close view of the potential interaction between LHM and the binding site of hAChE (pdb id: 1B41). Binding interactions of 
LHM in the catalytic site of TcAChE (green stick = compound 5). The most important residues involved in the interactions with 
LHM including the peripheral anionic site (PAS) and anionic sub-site (choline-binding sub-site). (B): The 2D representation 
docking results of LHM with the residues in the active site of hAChE.(C): Interatomic contacts (yellow) of the ligand with the 



























Table 3.65: Effects of ZnHMS on biochemical parameters in rats 
 
Groups with different alphabets are statistically significant 
 
Table 3.66 Effects of ZnHMS on pH and mucus content in ethanol induced ulcerated rats 
 
Animals group Pre-treatments ALT (IU/L) AST (IU/L) C-reactive HD-L 
1 Normal 52.8 ± 1.5a 129 ± 6.3a 0.69 ± 1.3a 1.19 ± 0.9a 
2 Ethanol 149.8 ± 4.6b 299 ± 5.4b 0.12 ± 0.2b 0.39 ± 0.7b 
3 Omeprazole (20mg/Kg) 61.4 ± 2.4c 159 ± 6.2c 0.43 ± 0.1c 0.69 ± 0.4c 
4 ZnHMS-alone-60mg/Kg 58.3 ± 2.2c 136 ± 7.3a 0.61 ± 0.3a 1.07 ± 0.8a 
5 ZnHMS single dose 30 mg/Kg 84.0 ± 2.1d 198 ± 4.2d 0.28 ± 1.3d 0.51 ± 0.2c 
6 ZnHMS single dose 60 mg/Kg 68.1 ± 2.3d 187 ± 4.8d 0.31 ± 1.1d 0.48 ± 0.6c 
7 ZnHMS-Et- (30mg/Kg) 56.8 ± 2.4a 146 ± 5.3a 0.52 ± 1.3a 0.74 ± 0.9d 
8 ZnHMS-Et-(60mg/Kg) 54.2 ± 1.8a 137 ± 7.2a 0.67 ± 1.4a 1.14 ± 0.4a 
Animals Pretreatment(5ml/Kg) 





(mm) (mean + S.E.M) %Inhibition 
1 Normal 7.05 ± 0.6a 2.93 ± 0.2a 0 0 
2 Ethanol ulcer group 2.03 ± 0.4b 1.06 ± 2.1b 850.00 ± 14.43a - 
3 Omeprazole (20mg/Kg) 5.60 ± 0.5a 2.38 ± 0.4c 178.0 ± 9.6b 79.0 
4 ZnHMS-alone-60 mg/Kg 6.78 ± 0.4e 2.96 ± 0.3e 0 100 
5 ZnHMS (single dose;30 mg/Kg)+ethanol 2.62 ± 0.2d 2.59 ± 0.9d 510.0.± 7.2c 40.0 
6 ZnHMS (single dose; 60 mg/Kg)+ethanol 2.98 ± 0.2f 2.41 ± 0.9f 387.0 ± 6.1d 54.5 
7 ZnHMS (14 days, 30mg/Kg)+ethanol 6.80 ± 0.4a 2.54 ± 0.4a 78.00 ± 5.3e 90.8 








factor alpha  Interleukin-6 
Interleukin-10  
Animals  
Treatments*  Malondialdehyde 
(µmol/g Tissue)  
Nitric oxide 
(µmol) 
(pg/mg of stomach tissue) 
1 Normal 9.98 ± 2.67a 9.4 ± 1.81 a 9.10 ± 0.2 a 6.5 ± 0.3 a 453 ± 18 a 
2 Ethanol ulcer group 29 ± 1.40b 4.2 ± 0.3 b 610 ± 18 b 78 ± 4.1b 84 ± 5.2 b 
3 Omeprazole (20mg/Kg) 16.5 ± 0.9c 8.5 ± 1.4 a 104 ± 2.8c 8.2 ± 0.45 a 249 ± 5.7 c 
4 ZnHMS-alone-60 mg/Kg 10.5 ± 2.57c 9.3 ± 1.20 a 10.8 ± 0.8 a 7.5 ± 0.85 a 427 ± 24d 
5 ZnHMS (single dose;30 mg/Kg)+ethanol 19.6 ± 2.1d 5.8 ± 1.4 c 132 ± 2.7c 14.2 ± 2.3 c 158 ± 4.8 e 
6 ZnHMS (single dose; 60 mg/Kg)+ethanol 18.2 ± 1.8d 6.2 ± 1.5 c 105 ± 1.4 c 13.6 ± 2.8 c 189 ± 5.4 f 
7 ZnHMS (14 days, 30mg/Kg)+ethanol 10.0 ± 1.10 c 9.2 ± 0.9 a 75 ± 4.5 c 9.6 ± 1.2 a 305 ± 4.9 g 




Appendix K: Anticancer results  
Table 3.68: IC 50 concnentartions of ZnLNS, ZnLDH and ZnLHM on PC3, A-549, MCF-7 and HepG2 cell lines.  
 
 
Figure 3.181 Morphological changes of cells after 48 hours treatment for at IC50 concentration with compounds. Treated A-549 
(B), PC3 (D), HepG2 (F) and MCF-7 (H) cells were well compared with respective controls (A, C, E and G). 
 
 
